Literature DB >> 29512837

Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Santosh Kumar1.   

Abstract

Natural killer (NK) cells express an array of germ-line encoded receptors that are capable of triggering cytotoxicity. NK cells tend to express many members of a given family of signalling molecules. The presence of many activating receptors and many members of a given family of signalling molecules can enable NK cells to detect different kinds of target cells, and to mount different kinds of responses. This contributes also to the robustness of NK cells responses; cytotoxic functions of NK cells often remain unaffected in the absence of selected signalling molecules. NK cells express many MHC-I-specific inhibitory receptors. Signals from MHC-I-specific inhibitory receptors tightly control NK cell cytotoxicity and, paradoxically, maintain NK cells in a state of proper responsiveness. This review provides a brief overview of the events that underlie NK cell activation, and how signals from inhibitory receptors intercept NK cell activation to prevent inappropriate triggering of cytotoxicity.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  activating receptor; cytotoxic synapse; immunoreceptor tyrosine-based inhibitory motif (ITIM); inhibitory receptor; inhibitory synapse; killer-cell Ig-like receptor (KIR); natural killer cell

Mesh:

Substances:

Year:  2018        PMID: 29512837      PMCID: PMC6002213          DOI: 10.1111/imm.12921

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  133 in total

Review 1.  Ligands for natural killer cell receptors: redundancy or specificity.

Authors:  A Cerwenka; L L Lanier
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

Review 2.  Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold.

Authors:  David Chodniewicz; Richard L Klemke
Journal:  Biochim Biophys Acta       Date:  2004-07-05

3.  Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.

Authors:  Yatin M Vyas; Hina Maniar; Clay E Lyddane; Michel Sadelain; Bo Dupont
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

4.  Adhesion to target cells is disrupted by the killer cell inhibitory receptor.

Authors:  D N Burshtyn; J Shin; C Stebbins; E O Long
Journal:  Curr Biol       Date:  2000-06-29       Impact factor: 10.834

5.  A single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation.

Authors:  Santosh Kumar; Pabak Sarkar; Malcolm J W Sim; Sumati Rajagopalan; Steven S Vogel; Eric O Long
Journal:  J Immunol       Date:  2014-12-12       Impact factor: 5.422

6.  Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses.

Authors:  Dongfang Liu; Yenan T Bryceson; Tobias Meckel; Gaia Vasiliver-Shamis; Michael L Dustin; Eric O Long
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

7.  PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion.

Authors:  Colin M Segovis; Renee A Schoon; Christopher J Dick; Lucas P Nacusi; Paul J Leibson; Daniel D Billadeau
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

8.  p46, a novel natural killer cell-specific surface molecule that mediates cell activation.

Authors:  S Sivori; M Vitale; L Morelli; L Sanseverino; R Augugliaro; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

9.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

Review 10.  The adaptor protein Crk in immune response.

Authors:  Dongfang Liu
Journal:  Immunol Cell Biol       Date:  2013-10-29       Impact factor: 5.126

View more
  47 in total

1.  KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds.

Authors:  Emiliana Weiss; Heloisa S Andrade; Juliana Rodrigues Lara; Andreia S Souza; Michelle A Paz; Thálitta H A Lima; Iane O P Porto; Nayane S B Silva; Camila F Bannwart Castro; Rejane M T Grotto; Eduardo A Donadi; Celso T Mendes-Junior; Erick C Castelli
Journal:  Immunogenetics       Date:  2021-02-17       Impact factor: 2.846

2.  Natural killer cell transcriptional control, subsets, receptors and effector function.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2019-02       Impact factor: 7.397

Review 3.  Immune signalling by supramolecular assemblies.

Authors:  Santosh Kumar; Shweta Jain
Journal:  Immunology       Date:  2018-09-24       Impact factor: 7.397

Review 4.  Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far?

Authors:  Abdellatif Bouayad
Journal:  Rev Med Virol       Date:  2021-04-01       Impact factor: 11.043

Review 5.  The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.

Authors:  Tobias Bald; Matthew F Krummel; Mark J Smyth; Kevin C Barry
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

6.  Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells.

Authors:  Esti Toledo; Guillaume Le Saux; Avishay Edri; Long Li; Maor Rosenberg; Yossi Keidar; Viraj Bhingardive; Olga Radinsky; Uzi Hadad; Carmelo Di Primo; Thierry Buffeteau; Ana-Sunčana Smith; Angel Porgador; Mark Schvartzman
Journal:  Sci Adv       Date:  2021-06-11       Impact factor: 14.136

Review 7.  CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.

Authors:  Faroogh Marofi; Marwan Mahmood Saleh; Heshu Sulaiman Rahman; Wanich Suksatan; Moaed E Al-Gazally; Walid Kamal Abdelbasset; Lakshmi Thangavelu; Alexei Valerievich Yumashev; Ali Hassanzadeh; Mahboubeh Yazdanifar; Roza Motavalli; Yashwant Pathak; Adel Naimi; Behzad Baradaran; Marzieh Nikoo; Farhad Motavalli Khiavi
Journal:  Stem Cell Res Ther       Date:  2021-07-02       Impact factor: 6.832

Review 8.  NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.

Authors:  Paolo Sportoletti; Filomena De Falco; Beatrice Del Papa; Stefano Baldoni; Valerio Guarente; Andrea Marra; Erica Dorillo; Chiara Rompietti; Francesco Maria Adamo; Loredana Ruggeri; Mauro Di Ianni; Emanuela Rosati
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

Review 9.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

10.  Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.

Authors:  Emily Chiu; Martin Felices; Frank Cichocki; Zachary Davis; Hongbo Wang; Katie Tuninga; Daniel A Vallera; Tom Lee; Ryan Bjordahl; Karl Johan Malmberg; Bahram Valamehr; Jeffrey S Miller
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.